ロード中...
Mixed response and time-to-event endpoints for multistage single-arm phase II design
BACKGROUND: The objective of phase II cancer clinical trials is to determine if a treatment has sufficient activity to warrant further study. The efficiency of a conventional phase II trial design has been the object of considerable debate, particularly when the study regimen is characteristically c...
保存先:
| 出版年: | Trials |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4460691/ https://ncbi.nlm.nih.gov/pubmed/26037094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0743-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|